Amgen's strategic growth through M&A and R&D investments has led to a diversified portfolio. Find out why I give AMGN stock a ...

Eli Lilly (NYSE:LLY) shares climbed ~14% in the premarket on Thursday after the company said its oral GLP-1 receptor agonist orforglipron reached the main goal in a Phase 3 trial for adults with type ...

Dragged down by negative returns for shares of NVIDIA Corp. and Amgen, the Dow Jones Industrial Average is in a selloff Wednesday afternoon. The Dow was most recently trading 589 points lower (-1.5%), ...

In this week’s edition of InnovationRx, we look at the impact of Medicaid cuts, a $400 million obesity bet, a study of bias ...

After a lengthy regulatory back-and-forth, Eisai and Biogen's Alzheimer's drug is on the market in Europe. Elsewhere, Sandoz is alleging Amgen's patent actions were anticompetitive.

Advisors Capital Management upped its Amgen stake by 6.2% in Q4, scooping up an extra 3,427 shares valued at $15.3 million. Amgen’s fourth-quarter earnings beat expectations with a $5.31 per share ...

Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.

Alston & Bird allege their client has suffered more than $1 billion in lost sales from being unable to manufacture a ...

The health sector faces numerous challenges, including counterfeit Ozempic, a Sandoz antitrust lawsuit against Amgen, Trump's ...

In his 13 years as CEO at Amgen, Robert Bradway has seen many of his counterparts at other major biopharma companies come and ...